A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma
Clinical trial NCT00930683 · COMPLETED
Trial details
- NCT number
- NCT00930683
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-05-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.